V
Veracity Neuroscience, LLC. | Memphis, Tennessee
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
CVN424
ABP-450
Buntanetap
AMX0035
ABP-19000
Zoledronic Acid
Suvecaltamide
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 13 total trials
This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will...
Begins enrollment this month
Deep Brain Stimulation
Parkinson's Disease (PD)
Drug: buntanetap/posiphen
A35-009 (ORION) is a Phase 2b/3 trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consi...
Active, not recruiting
PSP
Neurodegenerative Diseases
Other: Placebo
Drug: AMX0035
This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Part...
Enrolling
Parkinson Disease
Drug: Placebo
Drug: CVN424 75 mg
Trial sponsors
A
A
A
C
C
C
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems